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ABSTRACT
In this study, we aimed to identify the myosin motor proteins that
control trafficking at the Golgi complex. In addition to the known
Golgi-associated myosins MYO6, MYO18A and MYH9 (myosin IIA),
we identified MYO1C as a novel player at the Golgi in a human cell line.
We demonstrate that depletion of MYO1C induces Golgi complex
fragmentation and decompaction. MYO1C accumulates at dynamic
structuresaround theGolgi complex that colocalizewithGolgi-associated
actin dots. MYO1C depletion leads to loss of cellular F-actin, and Golgi
complex decompaction is also observed after inhibition or loss of the
actin-related protein 2/3 complex, Arp2/3 (also known as ARPC). We
show that the functional consequence ofMYO1C depletion is a delay in
the arrival of incoming transport carriers, both from the anterograde and
retrograde routes. We propose that MYO1C stabilizes actin at the Golgi
complex, facilitating the arrival of incoming transport carriers at the Golgi.
Thisarticle hasanassociatedFirst Person interviewwith the first authorof
the paper.
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INTRODUCTION
The Golgi complex is the main hub of intracellular trafficking, at the
interface between anterograde and retrograde routes. Golgi membrane
dynamics are mandatory for efficient sorting of cargos traversing the
Golgi complex and require tensile forces from the cytoskeleton.
Particularly, actin-dependent myosin motor proteins have been
implicated in the formation of tubular membrane carriers and their
fission from the Golgi: historically, non-muscle myosin IIA (MYH9)
was first proposed to function in the production of vesicles from the
Golgi complex (Müsch et al., 1997). More recently, the depletion and
inhibition of myosin II induced the appearance of long, Golgi-derived,
Rab6 (also known as Rab6a)-positive membrane tubules, further
supporting its role in fission events during trans-Golgi network (TGN)
exit (Miserey-Lenkei et al., 2010). Myosin VI family memberMYO6,
a myosin moving towards the minus ends of F-actin, has also been
found on Golgi membranes, and was shown to play a role in Golgi
ribbon formation and exocytic events (Warner et al., 2003). Moreover,
MYO18A, MYO1B and MYO5B were additionally proposed to
control the formation of tubular and vesicular membrane carriers from
Golgi andTGNmembranes (Dippold et al., 2010;Almeida et al., 2011;
Liu et al., 2013). Interestingly, although Golgi-associated myosins
belong to different classes, they all have been proposed to facilitate exit
from the Golgi complex. Here, we aimed to systematically analyze the
myosins that regulate trafficking at the Golgi level, and to characterize
the underlying molecular mechanisms by which they regulate Golgi
membrane dynamics.
RESULTS
Identification of myosins that alter Golgi morphology
Defects in Golgi trafficking are characterized by changes in Golgi
morphology (Goud et al., 2018). Thus, we systematically depleted 36
myosins present in human and sought those that altered Golgi
morphology. We employed our approach combining cell culture on
adhesive micropatterns and quantification of organelle positioning by
probabilistic density mapping (Schauer et al., 2010, 2014; Duong et al.,
2012). We have previously shown that, when seeded on micropatterns,
the Golgi complex has a characteristic, well-defined, stable and
reproducible position, allowing automated detection of subtle changes
in its organization in a reduced number of cells (Schauer et al., 2010). In
three independent experiments, human telomerase-immortalized retinal
pigmented epithelial (hTertRPE-1) cells were transfected with a small
interfering RNA (siRNA) library targeting each myosin with four
independent siRNAs (Fig. 1A). The Golgi complex was analyzed in
fixed, crossbow-shaped micropatterned cells using our density-based
statistical analysis as previously reported (Duong et al., 2012; Schauer
et al., 2014). Hits were established by comparing each siRNA-treated
well with six control wells. We selected myosins for further analysis if
average Golgi morphology of a siRNA-treated well was significantly
different to those of three independent control wells (50% of control),
and reproducible for one specific siRNA in three independent
experiments (Fig. 1B, red dots) or for two siRNAs in two
independent experiments (Fig. 1B, orange dots). This was the case for
17 myosins (∼50%) from seven different classes. We next tested the
expression level of the identifiedmyosins in hTertRPE-1 cells (Fig. 1C).
Class II skeletal and cardiac muscle myosins, expected not to be
expressed in hTertRPE-1 cells, were expressed at the detection limit as
judged by analysis ofMYH6 andMYH15 (Fig. 1C, note the logarithmic
representation). We suspect that the presence of these hits is due to off-
target effects of the siRNAs and speculate that the absence of a target for
those siRNAs could be the reasonwhy theyexert strong effects onGolgi
morphology. Similarly, the expression levels of MYO3A, MYO10,
MYO15A and MYH11 were at the detection limit, rendering a further
analysis very challenging. However, the mRNA level of MYH9,
MYO1C, MYO18A and MYO6 was significant (expression >0.1%
of GAPDH level). Probability density maps of the Golgi complex of
pooled cells from significant wells revealed that gene silencing ofReceived 11 September 2018; Accepted 1 March 2019
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MYO1C, MYO6 and MYO18 increased the area in which Golgi
structures were found compared to that in pooled control cells (Fig. 1D).
However, gene silencing ofMYH9 decreased the area of the 50%Golgi
complex probability contour (Fig. 1D). MYH9, MYO18A and MYO6
have been all reported to regulate trafficking at the Golgi level (Dippold
et al., 2010; Müsch et al., 1997; Miserey-Lenkei et al., 2010; Warner
et al., 2003), validating our density-based analysis. To verify that
MYO1C depletion affects Golgi morphology, we tested all four siRNAs
used in the screen. We found that all four siRNAs reduced expression
levels of MYO1C under screen conditions (2 days of knockdown),
however only by 25–40% (Fig. S1A,B).We found that all four siRNAs
affected Golgi complex morphology, although not with the same
efficiency (Fig. S1C–E); the siRNA#3, identified under screen
conditions, showed the strongest phenotype. Thus, our analysis
identified MYO1C as a potential novel regulator at the Golgi complex.
Comparable analysis of Golgi morphology upon depletion of
different myosins
To further verify and characterize the identified myosins, we
analyzed the 3D cellular phenotypes for individual siRNAs (Fig. 2).
We used siRNA#1, which showed an intermediate phenotype under
screen conditions, to targetMYO1C for all further studies. The gene
expression of all identified myosins was reduced by 60–90% after
3 days of siRNA-induced gene silencing (Fig. S2A). Representative
images of single cells (Fig. 2A) and the volume of the 3D density
maps of ∼100 cells from three independent experiments confirmed
that gene silencing of MYO1C, MYO6 and MYO18 increased the
area in which Golgi structures were found, compared to that in
pooled control cells, whereas gene silencing of MYH9 slightly
decreased this area (Fig. 2B,C). Moreover, automated detection of
individual Golgi structures in single cells revealed that depletion of
MYO1C and MYO18A significantly increased the average number
of detectable Golgi structures per cell, indicating Golgi complex
fragmentation (Fig. 2D). Depletion of MYH9 significantly
decreased the average number of Golgi structures per cell.
Dividing the average numbers of structures per cell by the average
volume of the 3D density map indicated that depletion of MYO1C
and MYO6 de-compacted the Golgi complex by 40% and 25%,
respectively. Depletion ofMYO18A led to a 50% compaction of this
organelle, whereas gene silencing of MYH9 did not change
Fig. 1. Identification of myosins that alter Golgi morphology. (A) Workflow for the systematic, comparative analysis, combining cell culture on adhesive
micropatterns and quantification of organelle positioning by probabilistic density mapping: hTertRPE-1 cells were transfected with an siRNA library targeting
each myosin with four independent siRNAs, incubated for 48 h and transferred to crossbow-shaped micropatterned plates. After 3 h spreading, cells were fixed,
and the Golgi complex was stained with anti-GM130 antibody and imaged, followed by image processing and density-based statistical analysis. (B) A list of
candidate myosins that were further investigated was established on the following criteria: average density map of the Golgi complex was significantly
different to those of three independent control wells, and reproducible for one specific siRNA in three independent experiments (red dots) or for two siRNAs
in two independent experiments (orange dots). Black dots represent not significant hits. (C) The expression level of the identified myosins (excluding members of
skeletal and cardiacmusclemyosins) in hTertRPE-1 cells as a percentage of GAPDHexpression. Error bars represent the s.d. of three independentmeasurements.
(D) Overlap of the 50% contour of the 2D density estimation map calculated in control cells (black) or cells depleted of the indicated myosin (red), n=number of
analyzed cells.
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compaction of the Golgi complex to more than 10% (Fig. 2D).
Thus, our results indicate that MYO1C and MYO6 depletion
de-compacts the Golgi complex, whereas depletion ofMYO18A and
MYH9 leads to a more compact or smaller Golgi complex,
increasing the number of Golgi structures in the case of MYO18A
silencing, and decreasing the Golgi area and number of Golgi
structures downstream of MYH9 depletion.
MYO1C controls Golgi morphology
We next studied the function of MYO1C at the Golgi (employing
siRNA#1, see Fig. S1). As expected frommRNA levels, theMYO1C
protein level was reduced by 80% after 3 days of siRNA treatment
(Fig. S2B,C). Analysis of the Golgi morphology in classical,
unconstrained cell culture conditions confirmed that the Golgi
complex was fragmented and the 2D projected Golgi area was
significantly increased uponMYO1C depletion (Fig. 3A,B). Notably,
all tested Golgi markers, the matrix protein GM130 (also known as
GOLGA2), the cis-Golgi protein Giantin (also known as GOLGB1)
and the TGN protein TGN46 (also known as TGOLN2), exhibited
altered morphology. Rescue experiments through the transient
overexpression of a GFP-MYO1C construct (of the rat homolog)
that is resistant against knockdown by the siRNA used in this study
failed in hTertRPE-1 cells because of cell death after transfection.
Thus, we performed rescue experiments in previously characterized
stable HeLa cell lines that express either GFP-tagged humanMYO1C
or mouse MYO1C (Maliga et al., 2013). Gene silencing of MYO1C
strongly decreased expression of the endogenous MYO1C in all
HeLa cells, as well as the overexpressed humanGFP-MYO1C but not
the mouse GFP-MYO1C (Fig. S2D,E). As expected, the Golgi
complex expanded after siRNA treatment of HeLa cells expressing
the human protein, but not in HeLa cells expressing the mouse
isoform (Fig. S2F). Because HeLa cells show a more heterogeneous
morphology of the Golgi, the 75% probability contour representing
75% of all Golgi structures was plotted. We also noticed that the
Golgi seems to be slightly smaller after siRNA treatment in HeLa
cells expressing the mouse MYO1C. In hTertRPE1 cells, the
overexpression of a GFP-MYO1C construct (of the rat homolog)
led to a significant compaction of the Golgi complex that was not
detected after the expression of GFP alone (Fig. 3C,D). To study
Golgi complex alterations at the ultrastructural level, we examined the
MYO1C-depleted cells using electronmicroscopy (EM). EM showed
that the characteristic structure of Golgi stacks, comprising four to six
cisternae with a typical cis-trans Golgi and endoplasmic reticulum
(ER) membrane, was similar in MYO1C-depleted cells and control
cells. Although the Golgi appeared less compact, EM confirmed that
the Golgi complex was dispersed and not swollen (Fig. 3E).
Fig. 2. Comparable analysis of Golgi morphology upon depletion of different myosins. (A) Fluorescent images representing the maximum intensity
projections (MIPs) of the Golgi complex labeled by anti-GM130 in single, representative hTertRPE-1 cells depleted of the indicated myosin and seeded on a
crossbow-shaped micropattern. Scale bar: 10 µm. (B) 3D 50% density map of the Golgi complex as in A. n=number of analyzed cells. Axes are in pixels,
100 pixels=6.45 µm. (C) Volume of the 50% contour of the Golgi complex as in B. (D) Quantification of the average numbers of Golgi structures per cell as in
B. Error bars represent the s.d. of three independent experiments. ***P<1×10−4, Student’s t-test. (E) Quantification of the compaction of the Golgi complex,
dividing the average number of Golgi structures per cell by the volume of the 50% probability contour.
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MYO1C accumulates at the Golgi proximity by pleckstrin
homology domain and colocalizes with actin spots
We next investigated the cellular localization of MYO1C.
Immunofluorescent staining of endogenous MYO1C or
overexpression of GFP-MYO1C indicated that the majority of
MYO1C was at the plasma membrane, as expected (Ruppert et al.,
1995). However, in addition to this major pool, we identified
MYO1C-containing spots in close apposition to the Golgi complex
(Fig. 4A–C; Fig. S3A). Overexpressed GFP-MYO1C showed similar
distribution to the endogenous protein, as quantified by average
intensity projections of fluorescent images and density maps of
endogenous and overexpressed MYO1C in micropatterned cells, and
the average expression of GFP-MYO1C protein was comparable to
endogenous levels (Fig. S3B–D). Previous analysis has identified
recycling endosomes that are found close to the Golgi complex as an
additional intracellular localization of MYO1C (Brandstaetter et al.,
2012). Thus, we performed colocalization analysis of endogenous
and overexpressed GFP-MYO1C with different markers of
intracellular compartments: the TGN protein TGN46, the recycling
endosome-specific Rab11 (also known as Rab11a) GTPase, the late
endosomal/lysosomal protein Lamp1 and the early endosomal
marker EEA1 (Fig. S4). Additionally, we used the colocalization
between MYO1C and actin visualized by Ftractin (Johnson and
Schell, 2009) as a positive control, showing strong colocalization.
Colocalization analysis was performed in several tens of cells using
an object-based method, in which two structures were considered
colocalized if the distance between their centroids was found to be
inferior to the optical resolution limit. We found that, on average,
18% and 19% of endogenous or overexpressed MYO1C colocalized
with TGN46 and Rab11, respectively (Fig. 4D; see Fig. S4C for
individual experiments). The colocalization with other endosomal
markers was less: we found 10% and 6% colocalization with late
endosomes and early endosomes, respectively. Thus, our analysis
indicates that a significant intracellular MYO1C pool is found on
recycling endosomes and late endosomes, as previously reported, as
well as on the TGN.
Live-cell imaging of GFP-MYO1C revealed that MYO1C-
positive structures moved around the Golgi complex (Fig. 4E;
Movie 1). Moreover, we found that both endogenous MYO1C and
GFP-MYO1C colocalized with actin spots at the Golgi (Fig. 5A,B).
To verify that the recruitment of MYO1C in the proximity of the
Golgi complex was independent of its actin-dependent motor
activity, as previously reported (Tang and Ostap, 2001;
Pyrpassopoulos et al., 2012), we compared accumulation of the
Fig. 3. MYO1C controls Golgi morphology. (A) Immunofluorescent staining of different Golgi markers – the matrix protein GM130 (green), the cis-Golgi
protein Giantin (red) and the TGN protein TGN46 (magenta) – in representative control (top) and MYO1C-depleted (bottom) hTertRPE-1 cells in classical,
unconstrained culture conditions. Nuclei are stained with DAPI (blue). Scale bars: 10 µm. (B) Quantification of the 2D projected Golgi area in control conditions
(n=145) and upon MYO1C depletion (n=165). Error bars represent the s.d. of three independent experiments; n=number of analyzed cells. ***P<1×10−4,
Student’s t-test. (C) Fluorescent images of representative hTertRPE-1 cells expressing GFP or GFP-MYO1C (green) and stained for the Golgi complex
(red, GM130). Scale bars: 10 µm. (D) Quantification of the 2D projected Golgi area (stained by GM130) of non-transfected cells and cells as in C. Error bars
represent the s.d. of three independent experiments with n>40 cells for each condition. *P<1×10−2, Student’s t-test, average of three independent experiments.
(E) EM images of representative intracellular areas of unconstrained hTertRPE-1 cells containing the Golgi complex in control conditions (left) and upon MYO1C
depletion (right). Scale bar: 1 µm.
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overexpressed GFP-MYO1C with that of an actin-binding mutant
GFP-MYO1CΔABL (Joensuu et al., 2014), in which the myopathy
loop (323–330; IIAKGEEL) was replaced by AGA tripeptide,
disrupting the essential hydrophobic interactions between the
myosin head domain and actin filaments (Fig. 5C). Additionally,
we analyzed the accumulation of a truncated construct (GFP-Tail)
containing only the MYO1C lipid-binding pleckstrin homology
(PH) domain (Hokanson et al., 2006; Oh et al., 2013).We found that
GFP-MYO1CΔABL formed the same numbers of spots at the Golgi
as the non-mutated GFP-MYO1C, indicating that accumulation of
MYO1C in the proximity of the Golgi complex (marked by
GM130) is independent of its actin-dependent motor activity
(Fig. 5D,E). Overexpression of the GFP-Tail increased the presence
of Golgi-associated spots, indicating that the PH domain is
responsible for accumulation around the Golgi. Interestingly, the
expression of either GFP-MYO1CΔABL or the GFP-Tail did not
change Golgi complex area (Fig. S3E), indicating that both
constructs did not show dominant-negative effects in hTertRPE1
cells. Together, these results indicate that MYO1C accumulates in
the proximity of the Golgi complex by its PH domain and that
Fig. 4. MYO1C accumulates at the Golgi proximity. (A) Fluorescent images of a representative, unconstrained hTertRPE-1 cell stained with anti-MYO1C
antibody to visualize the endogenous protein (green), anti-TGN46 antibody to visualize the Golgi complex (red) and DAPI to visualize the nucleus (blue).
(B,C) Fluorescent images of representative, micropatterned hTertRPE-1 cells expressing GFP-MYO1C (green), and stained for the Golgi complex with
anti-TGN46 or anti-Giantin antibody (red) and for the nucleus with DAPI (blue). Yellow arrows indicate MYO1C-positive structures at the Golgi complex proximity.
(D) Colocalization analysis of endogenous or overexpressed GFP-MYO1C with the following markers: anti-TGN46 (TGN), Rab11 (recycling endosomes),
Lamp1 (late endosomes/lysosomes), EEA1 (early endosomes) and Ftractin (actin cytoskeleton). Colocalization analysis was performed using an object-based
method, in which two structures were considered colocalized if the distance between their centroids (from automated segmentation) was inferior to the
optical resolution limit (350 nm X-Y, 900 nm Z). Colocalization results are given as the percentage of colocalized structures over the total numbers of
MYO1C-positive structures. Error bars represent the s.d. of four independent experiments for TGN46, three independent experiments for Rab11 and two
independent experiments for Lamp1. The individual experiments with analyzed cell numbers are shown in Fig. S4. (E) Fluorescent images of a time-lapse
acquisition of unconstrained hTertRPE-1 cells expressing GFP-MYO1C (green) and mCherry-Rab6 (red). Scale bars: 10 µm. White solid and dashed arrows
indicate two independent MYO1C-positive structures moving around the Golgi complex.
5













interaction of MYO1C with actin is important for Golgi
morphology changes.
MYO1C controls the cellular actin cytoskeleton
Next, we investigated the organization of the actin cytoskeleton in the
presence and absence of MYO1C, employing micropatterned,
normalized cells for better comparison. Although actin protein levels
were not changed uponMYO1C depletion (Fig. 6A), staining of F-actin
with phalloidin in normalized cells revealed a decrease in actin fibers
throughout the cell uponMYO1C depletion (Fig. 6B). This suggested
that MYO1C stabilizes F-actin. Thus, we wondered whether actin
depolymerization by different drugs could mimic MYO1C depletion.
We treated cells with Latrunculin A (LatA), to disrupt actin filaments
(200 nM for 20 min), and CK666, an inhibitor of the Arp2/3 (also
known as ACTR2/3) complex, to inhibit branched actin formation
(100 µM for 20 min), and observed the Golgi complex in hTertRPE-1
cells stably expressing theGolgimarker GFP-Rab6 (Fig. 6C).Whereas
LatA treatment did not increase Golgi complex area, the loss of
branched actin after inhibition of the Arp2/3 complex by CK666
significantly increased the Golgi complex area (Fig. 6D). Similarly,
targeting ACTR3 of the Arp2/3 complex by siRNA resulted in a
fragmented Golgi and an increase in Golgi area compared to that of
control in micropatterned cells (Fig. 6E,F). These results indicate that
MYO1C depletionmimics loss of branched actin. To further investigate
the interaction of MYO1C with the actin cytoskeleton, we performed
super-resolution microscopy based on single-molecule localization of
MYO1C and phalloidin-stained actin. Interestingly, we observed that
MYO1C is frequently found at branched actin filaments (Fig. S5).
Based on our results, we speculate that MYO1C stabilizes branched
actin close to cellular membranes including the Golgi complex.
Fig. 5. MYO1C colocalizes with actin at the Golgi proximity but its recruitment is independent of its actin-binding domain. (A) Fluorescent images
of a representative, unconstrained hTertRPE-1 cell stained with anti-MYO1C antibody to visualize the endogenous protein (green), TGN46 antibody to
visualize the Golgi complex (magenta) and phalloidin to visualize the actin cytoskeleton (red). The nucleus is stained with DAPI (blue). (B) Fluorescent
images of representative, micropatterned hTertRPE-1 cells expressing GFP-MYO1C (green), and stained with phalloidin to visualize F-actin (red) and DAPI
to visualize the nucleus (blue). Arrows indicate MYO1C-positive structures that colocalize with Golgi-associated actin spots. (C) Domain structure of MYO1C,
the mutant form MYO1CΔABL and the truncated Tail domain. (D) Fluorescent images of representative hTertRPE-1 cells expressing GFP-MYO1C,
GFP-MYO1CΔABL or GFP-Tail (green), stained for the Golgi complex (magenta, GM130) and F-actin (red, phalloidin). (E) Quantification of GFP-positive spots
at the Golgi area as in D for GFP (n=24), GFP-MYO1C (n=49), GFP-MYO1CΔABL (n=56) or GFP-Tail (n=34). The percentage of cells that contain 0 (light gray),
1–10 (dark gray) or more than 10 (black) Golgi-associated spots per cell is shown. Note that control (GFP-expressing) cells never contained more than one
Golgi-associated spot per cell. n=number of analyzed cells. Scale bars: 10 µm.
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MYO1C delays arrival from anterograde and retrograde
trafficking at the Golgi complex
To study the functional consequences ofMYO1C depletion, we next
investigated trafficking through the Golgi complex by live-cell
imaging. Employing the retention of different reporter proteins in the
ER using selective hooks (RUSH) system (Boncompain and Perez,
2012), we monitored synchronized anterograde transport of GFP-
TNFα (also known as TNF) from the ER to the plasma membrane
after release of the reporter from the hook. As previously reported,
GFP-TNFα accumulated at the Golgi between 10 min and 15 min
post-release (Boncompain et al., 2012), which we measured as an
increase in the ratio between mean intensity of GFP-TNFα in
GM130-positive Golgi area and a random cytosolic area of the same
size (Fig. 7A,B). Depletion ofMYO1C led to a significant delay in the
arrival at the Golgi complex at 10 min post-release. In contrast, no
difference between control and siMYO1C was detected after 35 min
post-release, suggesting that the exit of GFP-TNFα from the Golgi is
not delayed uponMYO1C depletion, althoughwe cannot exclude that
effects onGolgi exit aremasked by the different kinetics duringGolgi
arrival/transit. We additionally analyzed a second cargo, GFP-CD59,
for which transport through the Golgi follows slower kinetics than
those of TNFα: GFP-CD59 passed the Golgi between 20 min and
45 min post-release. Consistently, we found that depletion ofMYO1C
significantly delayed the arrival of GFP-CD59 at the Golgi,
accumulating there only 45 min post-release (Fig. S6A,B). The
Golgi complex can receive cargo from the retrograde pathway
(Mallard et al., 1998). Thus, we next tested accumulation of Shiga
toxin subunit B (STxB) at the Golgi during its trafficking from pre-
loaded endosomes to the ER according to standard protocols. STxB
accumulated in the Golgi complex starting at 15 min post-release
from endosomes, as previously reported. Again, we observed a
significant delay in Golgi arrival uponMYO1C depletion (Fig. 7C,D)
at 15 min and 90 min post-release from endosomes. At 240 min post-
release, no differences between control and siMYO1Cwere detected,
indicating that the exit of STxB from the Golgi was not delayed upon
MYO1C depletion. Thus, MYO1C facilitates the arrival at the Golgi
from either anterograde or retrograde routes.
DISCUSSION
Our work identifies MYO1C as a novel trafficking regulator at the
Golgi complex. Based on our results we propose that MYO1C
localizes in the proximity of the Golgi complex through its PH
Fig. 6. MYO1C controls cellular actin
cytoskeleton. (A) Western blot analysis
of actin and GAPDH expression levels in
control and MYO1C-depleted hTertRPE-1
cells (top) and densitometry quantification
(bottom). Error bars represent the s.d.
of three independent experiments.
(B) Fluorescent images representing
the maximum intensity projections (MIPs)
of F-actin stained by phalloidin in
representative control and MYO1C-
depleted hTertRPE-1 cells seeded on a
crossbow-shaped micropattern (top row).
Average intensity projection of the MIP
images from n cells from three independent
experiments (bottom row). (C) Fluorescent
images of representative, unconstrained
hTertRPE-1 cells stably expressing
GFP-Rab6 in control conditions and
upon treatment with LatA and CK666.
(D) Quantification of the 2D projected Golgi
area (visualized by GFP-Rab6) in control
conditions (n=14) and upon treatment with
LatA (n=19) and CK666 (n=15). Error
bars represent the s.d. of individual
cells. *P<1×10−2, Student’s t-test.
(E) Fluorescent images representing the
MIP of the Golgi complex (visualized by
GFP-Rab6) in single, representative
hTertRPE-1 cells in control conditions and
upon ACTR3 depletion on a crossbow-
shaped micropattern. (F) Quantification of
the 2D projected Golgi area (visualized by
GFP-Rab6) in control conditions (n=25) and
in ACTR3-depleted hTertRPE-1 cells
(n=26). Error bars represent the s.d. of
individual cells. ***P<1×10−4, Student’s
t-test. n=number of analyzed cells. Scale
bars: 10 µm.
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domain, where it stabilizes actin and facilitates the arrival of
incoming transport carriers (Fig. 7E). This proposed function of
MYO1C differs substantially from those described for other Golgi-
associated myosins, which have all been implicated in cargo exit
from the Golgi complex. Indeed, myosins are required for the
production of tensile forces for deformation of Golgi complex
membranes for efficient tubule and vesicle formation and fission.
Our work proposes that MYO1C is required for incoming Golgi
cargos, organizing a scaffold of actin to facilitate the arrival of
cargos at membranes. However, we cannot ascertain that Golgi-
associated MYO1C dictates trafficking effects at the Golgi, because
MYO1C supports various cellular events, including the cellular
distribution of cholesterol-enrichedmembranes (Brandstaetter et al.,
2012). Thus, Golgi complex morphology could be affected by
global alterations in the integrity/dynamics of the actin cytoskeleton
and/or changes in overall vesicular traffic.
The best-studied function of MYO1C is its role in the docking of
GLUT4 (also known as SLC2A4)-containing vesicles to the plasma
membrane in response to insulin stimulation (Boguslavsky et al.,
2012; Bose et al., 2002, 2004; Chen et al., 2007; Huang et al., 2005;
Yip et al., 2008).More generally, MYO1C has been shown to regulate
exocytosis in secretory cells: MYO1C has been implicated in the
VEGF (also known as VEGFA)-induced delivery of VEGFR2 (also
known as KDR) to the cell plasmamembrane (Tiwari et al., 2013) and
in surfactant exocytosis (Kittelberger et al., 2016). Concomitantly,
MYO1C has been localized to cholesterol-rich lipid microdomains at
the plasma membrane. However, in addition to this major pool,
MYO1C has also been found on recycling endosomes (Brandstaetter
et al., 2012). Considering these studies, and our results on the function
ofMYO1C at the Golgi, these findings indicate that MYO1C function
is not limited to a particular organelle or specific membrane, but could
more generally regulate the link between different cellular membranes
Fig. 7. MYO1C delays arrival from anterograde and retrograde trafficking at the Golgi complex. (A) Fluorescent images of representative, unconstrained
hTertRPE-1 cells stably expressing Str–KDEL_TNFα–SBP–GFP at the indicated time points after the release of TNFα–SBP–GFP from the ER in control
conditions and in siMYO1C-treated cells. (B) Quantification of the mean fluorescent intensity at the Golgi complex relative to a non-Golgi area of the same
size in control conditions (n between 63 and 128 for each time point) and uponMYO1C depletion (n between 55 and 114 for each time point). Error bars represent
the s.d. of three independent experiment. *P<5×10−2, Student’s t-test, average of three independent experiments. (C) Fluorescent images of representative,
unconstrained hTertRPE-1 cells loadedwith fluorescently labeled STxB at the indicated time points after release from pre-loaded endosomes in control conditions
and in siMYO1C-treated cells. (D) Quantification of the mean fluorescent intensity at the Golgi complex relative to a non-Golgi area of the same size in
control conditions (n between 40 and 50 for each time point) and upon MYO1C depletion (n between 40 and 49 for each time point). Error bars represent
the s.d. of three independent experiments. *P<5×10−2, Student’s t-test. n=number of analyzed cells. (E) Model of MYO1C function at the Golgi complex.
We propose that MYO1C accumulates in the proximity of the Golgi complex, on non-Golgi membranes, by its PH domain and stabilizes branched actin,
facilitating the arrival of incoming transport carriers at the Golgi complex. Dashed lines represent the outlines of cells. Scale bars: 10 µm.
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and the actin cytoskeleton. More particularly, we speculate that
stabilizing branched actin for the arrival of transport carriers could be a
general function of MYO1C in intracellular trafficking.
We evidence thatMYO1C depletion mimics the loss of the Arp2/
3 complex at the Golgi complex. This is in agreement with previous
surveys that many class I myosins appear to be able to recruit
directly or indirectly the Arp2/3 complex (Soldati, 2003).
Interestingly, Joensuu et al. (2014) have found that intracellular
actin filament arrays are decorated by both MYO1C and cortactin,
which is a good marker of branched actin networks in cells (Molinie
and Gautreau, 2018). They show that the depletion of MYO1C
abolished these actin structures and proposed that MYO1C is
required for formation of actin filament arrays. Interestingly, it has
been shown that manipulation of the expression of another class I
myosin, MYO1B, affects the distribution of Arp2/3 and associated
branched F-actin (Almeida et al., 2011). MYO1C has been
previously shown to alter actin architecture in neuronal growth
cones and at the immunological synapse in B cells (Joensuu et al.,
2014; Maravillas-Montero et al., 2011). Thus, we propose that
MYO1C reorganizes actin architecture. In the future, it will be
important to address how MYO1C molecularly stabilizes actin
filaments. So far, it is unclear whether myosin I motors influence
actin dynamics by direct binding to branching actin filaments,
or by recruitment of factors that are involved in nucleation,
polymerization and stabilization of actin filaments (McIntosh and
Ostap, 2016; McIntosh et al., 2018; Evangelista et al., 2000).
In addition to MYO1C, we have identified MYO6, MYO18
andMYH9 (myosin IIA) as regulators of Golgi complexmorphology
in our density-based analysis. Although this confirms previous
findings, the particular Golgi phenotype (for instance fragmentation,
compaction) upon the depletion of a myosin seems to vary and to
depend on several factors: (1) cell spreading, which can strongly
impact the phenotypes of intracellular organelles; (2) cell type,
reflecting variability in actin architectures; or (3) imaging techniques,
either visualizing a projected 2D area or the 3D volume of the Golgi
complex. For instance, MYO18A depletion has been reported to
prevent the lateral stretching of the Golgi complex often observed in
2D culture (Dippold et al., 2010). On the other hand, an expansion of
the Golgi in the vertical direction as a result of actin filament
disassembly downstream of MYO18A depletion was proposed by
Bruun et al. (2017). Our approach onmicropatterns has the advantage
that we can detect intracellular changes independently of changes in
cell adhesion, and thus allows comparison after the depletion of
different myosins in one cell type. Our results indicate that MYO1C
and MYO6 depletion de-compacts the Golgi complex, whereas
depletion ofMYO18A andMYH9 leads to a more compact or smaller
Golgi complex, increasing the number of Golgi structures in the case
of MYO18A silencing and decreasing the Golgi area and number of
Golgi structures downstream ofMYH9 depletion. In the future, it will
be important to address the difference or redundancy of the functions
of myosins, to classify their activities, and to detect potentially
synergetic and opposing (tug of war) roles. Quantitative comparative
studies under normalized culture conditions are required in the future
to comprehensively understand how the different myosins maintain
the structural and functional integrity of the Golgi complex.
MATERIALS AND METHODS
Cells and reagents
hTertRPE-1 cells (Invitrogen, Eugene, OR, USA) were grown in Dulbecco’s
modified Eagle medium (DMEM)/F12 medium (Life Technologies,
Carlsbad, CA, USA), supplemented with 10% fetal bovine serum (FBS;
Eurobio, Courtaboeuf, France), and 1% penicillin-streptomycin (Life
Technologies), in a humidified atmosphere containing 5% CO2. The RUSH
stable cell lines, either expressing Strep-KDEL_CD59–SBP–GFP in
hTertRPE-1 cells or Str–KDEL_TNFα–SBP–GFP in HeLa cells, were
kindly provided by Frank Perez (Institut Curie, France). The stable HeLa-
Kyoto BAC cell lines (human MYO1C-NFLAP, mouse MYO1C-NFLAP)
were from the Hyman laboratory (Max Planck Institute of Molecular Cell
Biology and Genetics, Dresden, Germany). For micropatterning experiments,
fibronectin was from Sigma-Aldrich (St. Louis, MO, USA), fibrinogen–Cy5
from Invitrogen, and poly-L-lysine(20)-grafted[3.5]-polyethyleneglycol(2)
(PLL-g-PEG) from SuSoS (Dübendorf, Switzerland). The PLL-g-PEG was
used at a final concentration of 0.1 mg/ml in 10 mM HEPES (pH 7.3)
solution. We used the following antibodies: mouse monoclonal anti-GM130
(1:1000; BD Biosciences, 610823), anti-MYO1C (1:100; Santa Cruz
Biotechnology, sc-136544) and anti-actin (1:5000; Sigma-Aldrich, A-2228);
rabbit polyclonal anti-Lamp1 (1:1000; Sigma-Aldrich, L1418 or Abcam,
ab24170); human monoclonal anti-tubulin (1:200; F2C-hFc) and anti-Giantin
(1:300; Recombinant Protein and Antibody Platform of the Institut Curie); and
sheep polyclonal anti-TGN46 (1:500; Bio-Rad, AHP500). FluoProbes 547H
(557/572 nm)-coupled phalloidin was from Interchim. Cy3-coupled STxB
was generously provided by Ludger Johannes (Institut Curie, Paris, France).
Nuclei were stained using 0.2 µg/ml 4′,6-diamidino-2-phenylindole (DAPI;
Sigma-Aldrich).
Cell transfection
Cells (200,000) were transfected in either six-well plates or 12-well plates
with 25 pmol/ml siRNA (Sigma-Aldrich) using Lipofectamine RNAiMAX
Transfection Reagent (5 μl/ml; Life Technologies). Cells were incubated for





Efficiency of siRNA gene silencing was verified by performing real-time
PCR on cell mRNA or western blotting on cell lysates after 3 days of
transfection. Controls were performed with siRNA targeting Luciferase.
DNA transfection was performed using X-tremeGENE9 (Roche) following
the manufacturer’s instructions. The plasmids used were GFP-MYO1C
(from Ana-Maria Lennon, Institut Curie, Paris, France), GFP-MYO1C
ΔABL (from Eija Jokitalo, Institute of Biotechnology, University of
Helsinki, Helsinki, Finland), MYO1C tail (from Woo Keun Song, Institute
of Science and Technology, Gwangju, Korea) and mCherry-Rab6. The
siRNA library targeting 36 myosins was kindly provided by Buzz Baum
(Rohn et al., 2014).
Screening procedure and analysis
An siRNA library targeting 36 myosin proteins (four siRNAs/gene; 10 nM)
was kindly provided by Baum Buzz (University College London, London,
UK). For siRNA transfection, hTertRPE-1 cells were seeded on black clear-
bottom 96-well plates (Perkin Elmer ViewPlate-96 Black, 6005182) at 70%
confluency and transfected using 0.3 µl/well INTERFERin (Polyplus
Transfection). Negative siRNA control (Luciferase, GL2) and a positive
lethal siRNA (KIF11) were used as transfection controls. After 48 h,
decreased cell viability in the lethal positive control wells served as an
indicator of successful transfection (beta-factor was over 4 for each individual
triplicate). Cells were then dissociated using Accumax™ solution (Sigma-
Aldrich) and transferred to micropatterned-printed 96-well plates (CYTOO,
Grenoble, France) containing crossbow micropatterns at a concentration of
4000 cells/well. Plates were kept at 37°C for 3 h and further cells were fixed
with 4% (w/v) formaldehyde for 15 min and processed for
immunofluorescence staining with anti-GM130 primary antibodies. After
washing three times with PBS, cells were stained with Cy3 donkey anti-
mouse (Interchim, 1/200) in PBS/0.2% bovine serum albumin (BSA)/0.05%
saponin for 1 h at 37°C. Nuclei were stained with 0.2 μg/ml DAPI (Sigma-
Aldrich). Three independent experiments were performed. Images were
acquired using the INCell2000 automated imager (GE Healthcare).
Acquisition was performed using a 20× dry objective and 42 fields per
well were acquired, giving rise to ∼150 single cells per well. Images were
sorted in ImageJ (http://imagej.nih.gov/ij/) using the Micropatterned Single
9













Cell Sorting (MSCS) plugin, as previously described (Grossier et al., 2014a).
Images of single micropatterned cells were segmented with multidimensional
image analysis (MIA), and the positional information of the Golgi complex
was employed for density-based statistical analysis. Each of the wells
containing cells transfected with siRNA against myosins was compared to six
control wells on the same plate. The pairwise comparison of endosomal
spatial distributions was carried out using the two-sample kernel density-
based test (Duong et al., 2012; Schauer et al., 2014). Conditions were
considered as hits if average Golgi morphology of a siRNA-treated well was
significantly different (P<0.0005) to those of three independent control wells,
and reproducible for one specific siRNA in three independent experiments or
for two siRNAs in two independent experiments.
Micropatterned coverslip preparation and cell seeding
Micropattern production was as previously described (Azioune et al., 2009)
using photo-lithography methods. Briefly, coverslips were coated with
PLL-g-PEG and spatially controlled areas were exposed to deep UV light
for 5 min using a photomask. Crossbows (37 μmdiameter, 7 μm thick) were
therefore photo printed. Prior to cell seeding, the patterned substrates were
incubated for 1 h with fibronectin at a concentration of 50 μg/ml. The
fibronectin mixture was supplemented with 10 μg/ml fibrinogen–Cy5 to
stain the micropatterns. Cells were seeded on micropatterns in DMEM/F12
medium supplemented with 10 mM HEPES for 3 h prior to experiments.
Drug treatments
To induce cytoskeleton changes, the following drugs were used at the
indicated concentrations for 20 min: 200 nMLatA (Sigma-Aldrich, L5163),
100 µM CK666 (Sigma-Aldrich, SML0006). Dimethyl sulfoxide (DMSO)
was used for control conditions.
Immunofluorescence
For immunofluorescence, formaldehyde-fixed cells were washed three times
with PBS and permeabilized in PBS/0.2% BSA/0.05% saponin. Cells were
then incubated with a primary antibody for 1 h, washed in PBS and incubated
with Alexa-Fluor-488- or Cy3-coupled secondary antibodies (Jackson
ImmunoResearch). Slices were mounted in Mowiol (Sigma-Aldrich).
Synchronization of protein secretion by RUSH system
Stable cell lines expressing Strep-KDEL_CD59–SBP–GFP (hTertRPE-1
cells) and Str–KDEL_TNFα–SBP–GFP (HeLa cells) were transfected with
MYO1C-siRNA or Luciferase-siRNA. After 72 h, cells were treated with
40 μM biotin to allow the reporter release into the secretory pathway. Cells
were fixed at the indicated time points after biotin addition, stained with
antibody against GM130 and imaged.
STxB assay
hTertRPE-1 cells were transfected with MYO1C-siRNA or Luciferase-
siRNA. After 72 h, cells were incubated with Cy3-STxB (1 μg/ml) for 1 h at
19°C to load STxB in early and recycling endosomes, followed by three
washes with PBS. Fresh medium was added, and cells were transferred at
37°C for 15, 90 and 240 min, fixed, stained with antibody against GM130
and imaged.
EM
hTertRPE-1 cells were transfected with siRNA-MYO1C or siRNA-LUC for
72 h and chemically fixed with 2% glutaraldehyde and 1% paraformaldehyde
in NaHCa buffer (100 mM NaCl, 30 mM HEPES, and 2 mM CaCl2 at pH
7.4). The specimens were post-fixed with 1% OsO4/1.5% K4Fe(CN)6,
dehydrated with a graded ethanol series and embedded in Epon 812 (TAAB
Laboratories Equipment). Ultrathin sections were mounted on EM grids, and
stained with uranylacetate and lead citrate. Sections were observed with a
transmission electron microscope (Tecnai Spirit, Thermo Fisher Scientific,
Eindhoven, Netherlands) and digital acquisitions were made with a numeric
camera (Quemesa; EMSIS, Münster, Germany).
Single-molecule localization microscopy
Cells were pre-fixed with 0.2% glutaraldehyde/0.25% Triton X-100 in
PHEM (60 mM Pipes, 25 mM HEPES, 10 mM EGTA, 4 mM Mg acetate)
for 2 min at 37°C and fixed with 2% glutaraldehyde in PHEM for 10 min at
37°C, followed by washes with PBS and aldehyde reduction with NaBH4
(1 mg/ml in PBS) for 10 min. MYO1C was visualized through
immunofluorescence using anti-MYO1C (Santa Cruz Biotechnology, sc-
136544) primary antibodies and Alexa-Fluor-555-coupled secondary
antibodies. Actin was visualized by incubation with phalloidin-Alexa
Fluor 647 diluted in PBS/1% BSA for 1 h at 37°C. Samples were mounted
in dSTORM buffer (Abbelight, Paris, France). Then, 3D nanoscopy images
were taken using a SAFe360 module (Abbelight) coupled to the camera port
of an inverted bright-field Olympus IX71microscope, equipped with a 100×
oil-immersion objective with a high numerical aperture (NA; 1.49). This
quad-view system (dual-cam sCMOS cameras, Orcaflash v4, Hamamatsu)
provided 3D nanoscopy information with high isotropic localization
precision (15×15×15 nm, over an axial range of ∼1 mm). Axial
information was obtained by super-critical angle fluorescence (SAF) and
the point spread function (PSF) deformation with a strong astigmatism
(DAISY) (Cabriel et al., 2018). Twenty-thousand frames at 50 ms were
acquired to collect the single-molecule detections and reconstruct a
nanoscopy image. Resulting coordinate tables and images were processed
and analyzed using SAFe NEO software (Abbelight).
Fluorescent image acquisition
For micropatterned cells, Z-stack images from fixed and immunolabeled
cells were acquired with an inverted widefield Deltavision Core Microscope
(Applied Precision) equipped with a highly sensitive cooled interlined
charge coupled device (CCD) camera (CoolSnap Hq2, Photometrics). Z-
dimension series were acquired every 0.2 µm and out-of-focus signals were
reduced using deconvolution. Non-constrained cells were examined using a
3D deconvolution microscope (Leica DM-RXA2), equipped with a z-drive
(Physik Instrument) and 100×/1.4 NA PL-APO objective lens. Then, 3D or
1D multicolor image stacks were acquired using Metamorph software
(MDS) through a cooled CCD camera (Photometrics Coolsnap HQ). Z-
dimension series were acquired every 0.2 µm. For video microscopy
experiments, transfected cells were grown on glass-bottom Fluorodishes.
Video microscopy was performed at 37°C using a spinning-disk microscope
mounted on an inverted motorized microscope (Nikon TE2000-U) through
a 100×/1.4 NA PL-APO objective lens. The microscope was equipped with
a Yokogawa CSU-22 spinning-disk head, a Roper Scientific laser launch, a
Photometrics Coolsnap HQ2 CCD camera for image acquisition and MDS
to control the setup. Z-dimension series were acquired every 0.2 µm.
Image analysis
Golgi areawas selectedbasedonGM130 immunostaining and the area andmean
intensityweremeasured in ImageJ.Valueswere normalized to control conditions
(non-transfected, DMSO or siLUC). In anterograde and retrograde transport
assays, a small area in the Golgi (GM130 positive) and a random cytoplasmic
area of the same size was selected, and mean fluorescent intensities were
measured forGFP-TNFα,GFP-CD59andCy3-ShTxusing ImageJ.Valueswere
expressed as mean intensity ratio of Golgi/cytoplasm. Colocalization analysis
was performed with an in-house object-based macro in ImageJ as previously
described (Bolte and Cordelieres, 2006; Grossier et al., 2014b). Briefly, two
structures were considered colocalized if the distance between their centroids
(MIA segmentation output) were found inferior to the optical resolution limit
(350 nm in Z-Y, 900 nm in Z). Colocalization results are given as the percentage
of colocalized structures over the total number of structures.
Statistical analysis
For each experiment, a large number of cells were monitored from three
independent experiments. Data from independent experiments were
combined for representation, and statistical analysis was performed
employing a bilateral Student’s t-test.
Kernel density estimation
To extract the 3D spatial coordinates of intracellular structures, images of several
tens of cells were segmented with the MIA interface on MetaMorph (https://
www.moleculardevices.com/products/cellular-imaging-systems/acquisition-
and-analysis-software/metamorph-microscopy) based on wavelet
decomposition. The coordinates from all cells in one condition were aligned
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according to the micropattern as previously described (Grossier et al., 2014b;
Schauer et al., 2010). The aligned coordinates of the segmented structures were
processed for density estimation programmed in the ks library in the R
programming language (http://www.r-project.org): the probability density
function f for each data sample of n coordinates X1, X2, …, Xn was estimated.
We used a non-parametric, unbinned kernel density estimator. At each of the data
points, a kernel functionKwas centered. The kernel functionswere then summed
to form the kernel density estimator f̂ :




in which KH is the Gaussian kernel with mean zero and variance matrix H. To
estimateH (also known as the bandwidth), we used the plug-in selector in the ks
library that has been shown to be reliable for 2D and 3D spatial distributions. For
visualizing kernel density estimates, we used probability contours and the
extension libraries mvtnorm, rgl and miscd.
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